PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
iHealthcareAnalyst, Inc.

Press Release


Receive press releases from iHealthcareAnalyst, Inc.: By Email RSS Feeds:

Global Geriatric Medicines Market Analysis: Indications, Therapeutics, Growth Trends and Forecast to 2020, New Report by iHealthcareAnalyst, Inc.


Geriatric Medicines Market by Indication Types (Arthritis, Cancer, Cardiovascular, Neurological, Osteoporosis, Respiratory), and Therapeutic Areas (Analgesics, Anticoagulants, Antidiabetic, Antihypertensive, Antipsychotics, Proton Pump Inhibitors, Statins) 2016-2020.

Maryland Heights, MO, February 22, 2017 --(PR.com)-- The geriatric medicines market is estimated to reach nearly USD 659 Billion in 2020, expanding at a CAGR of 7.5% from 2016 to 2020, due to rising chronic diseases in elderly population worldwide and government support schemes.

Browse Geriatric Medicines Market by Indication Types (Arthritis, Cancer, Cardiovascular, Neurological, Osteoporosis, Respiratory), and Therapeutic Areas (Analgesics, Anticoagulants, Antidiabetic, Antihypertensive, Antipsychotics, Proton Pump Inhibitors, Statins) 2016-2020 at https://www.ihealthcareanalyst.com/report/geriatric-medicines-market/.

Geriatric medicine is a branch of medicine concerned with clinical, remedial, preventive, and social aspects of disorders usually among people aged 65 years and above. Geriatric medicine is a subspecialty of internal medicine or family medicine that deals with the complex medical and psychosocial problems of older adults, and it is rapidly evolving into both a hospital-based specialty and a specialty concerned with community care. The geriatric population requires more palliative care and support as compared with younger adults due to reduced immunity of the geriatrics. Increasing chronic diseases among geriatrics and favorable government initiative toward geriatric care is driving demand for geriatric medicines worldwide.

The global geriatric medicines market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the indication types (arthritis, cancer, cardiovascular, neurological, osteoporosis, respiratory, etc.), and therapeutic areas (analgesics, anticoagulants, antidiabetic, antihypertensive, antipsychotics, proton pump inhibitors, statins, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). The global geriatric medicines market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global geriatric medicines market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in the global geriatric medicines market and included in this report are Abbott Laboratories, Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Eli Lilly and Company, Novartis AG, Pfizer, Inc., Merck & Company Inc., GlaxoSmithKline plc and Sanofi S.A.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/geriatric-medicines-market/

About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com

Website: https://www.ihealthcareanalyst.com
Contact Information
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
Contact
https://www.ihealthcareanalyst.com/

Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.
Promote Your Business